These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4211396)

  • 1. [Dopamine release in the rat nigrostratum system after hydroxy-5 tryptophan administration].
    Portmann-Cristesco EM; Boissier JR
    C R Acad Hebd Seances Acad Sci D; 1974 Feb; 278(7):963-5. PubMed ID: 4211396
    [No Abstract]   [Full Text] [Related]  

  • 2. Partial protection from the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by Pro-Leu-Gly-NH2(PLG; MIF-1).
    Sheng JG; Xu DL; Yu HZ; Xu XR; Tang QM
    Life Sci; 1987 May; 40(20):2007-10. PubMed ID: 2437428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injection of 6-hydroxydopamine into the substantia nigra of the rat. II. Diffusion and specificity.
    Agid Y; Javoy F; Glowinski J; Bouvet D; Sotelo C
    Brain Res; 1973 Aug; 58(2):291-301. PubMed ID: 4756131
    [No Abstract]   [Full Text] [Related]  

  • 4. [The characteristics of a parkinsonian syndrome induced in an experiment by a deficiency of nigrostriatal dopamine and by stimulation of the cholinergic neurons of the caudate nucleus].
    Kryzhanovskiĭ GN; Atadzhanov MA; Voronina TA; Nerobkova LN
    Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(6):3-7. PubMed ID: 8160497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys.
    Graybiel AM; Moratalla R; Quinn B; DeLanney LE; Irwin I; Langston JW
    Adv Neurol; 1993; 60():34-9. PubMed ID: 8420148
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study.
    Lategan AJ; Marien MR; Colpaert FC
    Life Sci; 1992; 50(14):995-9. PubMed ID: 1372673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
    Glowinski J
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():233-46. PubMed ID: 769114
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dopamine concentration in the nigrostriatal system during electrical stimulation of the head of the caudate nucleus].
    Bazhenova SI; Saul'skaia NB
    Fiziol Zh SSSR Im I M Sechenova; 1979 Apr; 65(4):521-6. PubMed ID: 456666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sirinathsinghji DJ; Whittington PE; Audsley AR
    Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H; Engberg G; Pileblad E
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo voltammetric study of dopamine release in the striatum following microinjection of apomorphine into the substantia nigra zona reticulata.
    Kamata K; Sugimoto A; Kameyama T
    Jpn J Pharmacol; 1986 Mar; 40(3):472-7. PubMed ID: 3712872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychoactive agents in dogs with bilateral lesions in subcortical structures.
    Goldstein S; Himwich WA; Leiner K; Stout M
    Neurology; 1971 Aug; 21(8):847-52. PubMed ID: 5315220
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased dopamine metabolism in rat striatum after infusions of substance P into the substantia nigra.
    Waldmeier PC; Kam R; Stöcklin K
    Brain Res; 1978 Dec; 159(1):223-7. PubMed ID: 728796
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo release of dopamine from rat striatum, substantia nigra and prefrontal cortex: differential modulation by baclofen.
    Santiago M; Machado A; Cano J
    Br J Pharmacol; 1993 Jul; 109(3):814-8. PubMed ID: 7689406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranigral GABAergic drug effects on striatal dopamine activity.
    Sperber EF; Wurpel JN; Sharpless NS; Moshé SL
    Pharmacol Biochem Behav; 1989 Apr; 32(4):1067-70. PubMed ID: 2477863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum.
    Elsworth JD; Deutch AY; Redmond DE; Sladek JR; Roth RH
    Life Sci; 1987 Jan; 40(2):193-202. PubMed ID: 3491946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of dimethoxy dichloro vinyl phosphate and fluorostigmine on the cyclic nucleotide content and dopamine level in the brain nigrostriatal system].
    Golovko AI; Korovkin BF; Kutsenko SA; Savateev NV
    Farmakol Toksikol; 1985; 48(2):46-8. PubMed ID: 3996569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.
    Lindefors N; Brodin E; Tossman U; Segovia J; Ungerstedt U
    Exp Brain Res; 1989; 74(3):527-34. PubMed ID: 2468514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion.
    Sirinathsinghji DJ; Heavens RP; Richards SJ; Beresford IJ; Hall MD
    Neuroscience; 1988 Oct; 27(1):117-28. PubMed ID: 3264391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of systemic and intrastriatal injections of haloperidol on striatal dopamine and DOPAC concentrations in rats pretreated by section of nigrostriatal fibres.
    Wuerthele SM; Moore KE
    J Pharm Pharmacol; 1980 Jul; 32(7):507-10. PubMed ID: 6105192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.